AVROBIO (AVRO) Proxy Filing summary

Executive summary

• Annual meeting scheduled for June 6, 2025, with virtual participation available for shareholders.

• Shareholders are encouraged to review proxy materials and vote by June 5, 2025.

Voting matters and shareholder proposals

• Election of two directors: Alise Reicin, M.D. and Praveen Tipirneni, M.D.

• Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2025.

• Advisory approval of named executive officer compensation.

• Advisory vote on the frequency of future say-on-pay votes, with a recommendation for 1 year.

• Other business may be addressed as appropriate during the meeting.

Board of directors and corporate governance

• Board recommends voting in favor of all proposals and nominees.